ASHLEY HALFAST: Open Payments
NPI 1922483866 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 33 payments from 11 companies in 2025. Trend: 2023 $1,138 · 2024 $780 · 2025 $914
Food & beverage: $814Education: $100
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $203 |
| Alexion Pharmaceuticals, Inc. | 4 | $177 |
| Ferring Pharmaceuticals Inc. | 4 | $122 |
| CSL Behring | 3 | $86 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $70 |
| ABBVIE INC. | 2 | $63 |
| Aimmune Therapeutics, Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Melinta Therapeutics, LLC | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: VYNDAQEL, REBYOTA, SOLIRIS, Kcentra, ULTOMIRIS, JOURNAVX, DALVANCE, VOWST.
Industry payments across TX — which companies pay providers there.
